Abliva AB (publ) NTP.F Stock
Abliva AB (publ) Price Chart
Abliva AB (publ) NTP.F Financial and Trading Overview
| Abliva AB (publ) stock price | 0.01 EUR |
| Previous Close | 0.01 EUR |
| Open | 0.0093 EUR |
| Bid | 0.01 EUR x 1690000 |
| Ask | 0.03 EUR x 1630000 |
| Day's Range | 0.0093 - 0.0093 EUR |
| 52 Week Range | 0.0001 - 0.05 EUR |
| Volume | 1K EUR |
| Avg. Volume | 17 EUR |
| Market Cap | 14.92M EUR |
| Beta (5Y Monthly) | 1.179693 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NTP.F Valuation Measures
| Enterprise Value | 13.63M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.055688623 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Abliva AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.179693 |
| 52-Week Change | -34.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.05 EUR |
| 52 Week Low | 0.0001 EUR |
| 50-Day Moving Average | 0.01 EUR |
| 200-Day Moving Average | 0.0099455 EUR |
NTP.F Share Statistics
| Avg. Volume (3 month) | 17 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 1.06B |
| Float | 415.84M |
| Short Ratio | N/A |
| % Held by Insiders | 7.79% |
| % Held by Institutions | 49.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.15% |
| Return on Equity (ttm) | -93.81% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -66551000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 0.48 EUR |
| Current Ratio (mrq) | 17.737 |
| Book Value Per Share (mrq) | 0.167 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Abliva AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 81 |
| Phone | 46 4 62 75 62 20 |
| Website | https://abliva.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Q&A For Abliva AB (publ) Stock
What is a current NTP.F stock price?
Abliva AB (publ) NTP.F stock price today per share is 0.01 EUR.
How to purchase Abliva AB (publ) stock?
You can buy NTP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abliva AB (publ)?
The stock symbol or ticker of Abliva AB (publ) is NTP.F.
Which industry does the Abliva AB (publ) company belong to?
The Abliva AB (publ) industry is Biotechnology.
How many shares does Abliva AB (publ) have in circulation?
The max supply of Abliva AB (publ) shares is 2.16B.
What is Abliva AB (publ) Price to Earnings Ratio (PE Ratio)?
Abliva AB (publ) PE Ratio is now.
What was Abliva AB (publ) earnings per share over the trailing 12 months (TTM)?
Abliva AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Abliva AB (publ) company belong to?
The Abliva AB (publ) sector is Healthcare.